EP 1677789 A1 20060712 - ALKYNES I
Title (en)
ALKYNES I
Title (de)
ALKYNE I
Title (fr)
ALKYNES I
Publication
Application
Priority
- US 2004034517 W 20041020
- US 56071503 P 20031031
Abstract (en)
[origin: WO2005044266A1] The present invention is directed to novel compounds of formula (I), to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds. The novel compounds are useful in therapy, and in particular for the treatment of gastroesophageal reflux disease (GERD).
IPC 1-7
A61K 31/44; C07D 213/16; C07D 213/24; C07D 213/26; C07D 213/30; A61P 1/04
IPC 8 full level
C07C 15/48 (2006.01); C07C 22/04 (2006.01); C07C 25/24 (2006.01); C07C 43/205 (2006.01); C07C 43/225 (2006.01); C07D 213/16 (2006.01); C07D 213/22 (2006.01); C07D 213/24 (2006.01); C07D 213/26 (2006.01); C07D 213/30 (2006.01); C07D 213/38 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); C07C 15/48 (2013.01); C07C 22/04 (2013.01); C07C 25/24 (2013.01); C07C 43/205 (2013.01); C07C 43/225 (2013.01); C07D 213/16 (2013.01); C07D 213/22 (2013.01); C07D 213/26 (2013.01); C07D 213/30 (2013.01); C07D 213/38 (2013.01)
Citation (search report)
See references of WO 2005044266A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005044266 A1 20050519; CA 2549967 A1 20050519; CN 1870999 A 20061129; EP 1677789 A1 20060712; JP 2007510645 A 20070426
DOCDB simple family (application)
US 2004034517 W 20041020; CA 2549967 A 20041020; CN 200480030870 A 20041020; EP 04795653 A 20041020; JP 2006538084 A 20041020